DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells

Epigenetics

Volumn 8, Issue 1, 2013, Pages 66-78

  Fernández Sánchez, Alba ^a   Raneros, Aroa Baragaño ^a   Palao, Reyes Carvajal ^a   Sanz, Ana B ^b   Ortiz, Alberto ^c,d   Ortega, Francisco ^a,d   Suárez Álvarez, Beatriz ^a   López Larrea, Carlos ^a,d  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d Section of Nephrology   (Spain)

Author keywords

Curcumin; Cytotoxicity; DNA methylation; H3K9 acetylation; KLRK1 gene; NKG2D receptor

Indexed keywords

5AZA 2' DEOXYCYTIDINE; AZACITIDINE; CURCUMIN; GAMMA INTERFERON; GRANZYME B; HISTONE H3; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; UNCLASSIFIED DRUG;

ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; DEMETHYLATION; DNA SEQUENCE; DOWN REGULATION; EPIGENETICS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84872022423     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.23115     Document Type: Article

References (54)

1. Glienke J, Sobanov Y, Brostjan C, Steffens C, Nguyen C, Lehrach H, et al. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 1998; 48:163-73; PMID:9683661; http://dx.doi. org/10.1007/s002510050420.
2. López-Larrea C, Suárez-Alvarez B, López-Soto A, López-Vázquez A, Gonzalez S. The NKG2D receptor: sensing stressed cells. Trends Mol Med 2008; 14:179-89; PMID:18353724; http://dx.doi.org/10.1016/j. molmed.2008.02.004.
3. Maccalli C, Scaramuzza S, Parmiani G. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors. Cancer Immunol Immunother 2009; 58:801-8; PMID:19089424; http://dx.doi. org/10.1007/s00262-008-0635-x.
4. Fasth AE, Björkström NK, Anthoni M, Malmberg KJ, Malmström V. Activating NK-cell receptors costimulate CD4(+)CD28(-) T cells in patients with rheumatoid arthritis. Eur J Immunol 2010; 40:378-87; PMID:19904767; http://dx.doi.org/10.1002/ eji.200939399.
5. Pariente B, Mocan I, Camus M, Dutertre CA, Ettersperger J, Cattan P, et al. Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease. Gastroenterology 2011; 141:217-26, 226, e1-2; PMID:21600899; http://dx.doi.org/10.1053/j. gastro.2011.03.061.
6. Li WX, Pan HF, Hu JL, Wang CZ, Zhang N, Li J, et al. Assay of T-and NK-cell subsets and the expression of NKG2A and NKG2D in patients with newonset systemic lupus erythematosus. Clin Rheumatol 2010; 29:315-23; PMID:20012119; http://dx.doi. org/10.1007/s10067-009-1322-9.
7. de Menthon M, Lambert M, Guiard E, Tognarelli S, Bienvenu B, Karras A, et al. Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's). Arthritis Rheum 2011; 63:2116-26; PMID:21484763; http:// dx.doi.org/10.1002/art.30355.
8. Sáez-Borderías A, Gumá M, Angulo A, Bellosillo B, Pende D, López-Botet M. Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. Eur J Immunol 2006; 36:3198-206; PMID:17109473; http://dx.doi.org/10.1002/ eji.200636682.
9. Wang Y, Bai J, Li F, Wang H, Fu X, Zhao T, et al. Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B. Immunol Invest 2009; 38:434-46; PMID:19811419; http://dx.doi. org/10.1080/08820130902943105.
10. Alonso-Arias R, Moro-García MA, López-Vázquez A, Rodrigo L, Baltar J, García FM, et al. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) 2011; 33:591-605; PMID:21210234; http://dx.doi. org/10.1007/s11357-010-9200-6.
11. Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, et al. Coordinated induction by IL-15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004; 21:357-66; PMID:15357947; http://dx.doi.org/10.1016/j. immuni.2004.06.020.
12. Muntasell A, Magri G, Pende D, Angulo A, López-Botet M. Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection. Blood 2010; 115:5170-9; PMID:20393128; http://dx.doi.org/ 10.1182/blood-2009-11-256479.
13. Ventre E, Brinza L, Schicklin S, Mafille J, Coupet CA, Marçais A, et al. Negative regulation of NKG2D expression by IL-4 in memory CD8 T cells. J Immunol 2012; 189:3480-9; PMID:22942430; http://dx.doi. org/10.4049/jimmunol.1102954.
14. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419:734-8; PMID:12384702; http://dx.doi.org/10.1038/nature01112.
15. Peraldi MN, Berrou J, Dulphy N, Seidowsky A, Haas P, Boissel N, et al. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol 2009; 182:1696-705; PMID:19155520.
16. Della Chiesa M, Carlomagno S, Frumento G, Balsamo M, Cantoni C, Conte R, et al. The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46-and NKG2D-activating receptors and regulates NK-cell function. Blood 2006; 108:4118-25; PMID:16902152; http://dx.doi.org/10.1182/blood-2006-03-006700.
17. Burgess SJ, Marusina AI, Pathmanathan I, Borrego F, Coligan JE. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. J Immunol 2006; 176:1490-7; PMID:16424177.
18. Espinoza JL, Takami A, Yoshioka K, Nakata K, Sato T, Kasahara Y, et al. Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions. Haematologica 2012; 97:1295-303; PMID:22491735; http://dx.doi. org/10.3324/haematol.2011.058529.
19. González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol 2008; 29:397-403; PMID:18602338; http://dx.doi. org/10.1016/j.it.2008.04.007.
20. Eagle RA, Traherne JA, Hair JR, Jafferji I, Trowsdale J. ULBP6/RAET1L is an additional human NKG2D ligand. Eur J Immunol 2009; 39:3207-16; PMID:19658097; http://dx.doi.org/10.1002/ eji.200939502.
21. Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y. NKG2D function protects the host from tumor initiation. J Exp Med 2005; 202:583-8; PMID:16129707; http://dx.doi.org/10.1084/ jem.20050994.
22. Zloza A, Lyons GE, Chlewicki LK, Kohlhapp FJ, O'Sullivan JA, Lacek AT, et al. Engagement of NK receptor NKG2D, but not 2B4, results in self-reactive CD8+ T cells and autoimmune vitiligo. Autoimmunity 2011; 44:599-606; PMID:21913803; http://dx.doi.org /10.3109/08916934.2011.593599.
23. Suárez-Álvarez B, Fernández-Sánchez A, López-Vázquez A, Coto E, Ortega F, López-Larrea C. NKG2D and its ligands: active factors in the outcome of solid organ transplantation? Kidney Int Suppl 2011; 1:52-7; http://dx.doi.org/10.1038/kisup.2011.13.
24. Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172:3652-61; PMID:15004168.
25. Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J, Speck SH, Boss JM, et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol 2006; 176:4083-93; PMID:16547244.
26. Akimzhanov AM, Yang XO, Dong C. Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation. J Biol Chem 2007; 282:5969-72; PMID:17218320; http://dx.doi.org/10.1074/jbc. C600322200.
27. Li G, Yu M, Weyand CM, Goronzy JJ. Epigenetic regulation of killer immunoglobulin-like receptor expression in T cells. Blood 2009; 114:3422-30; PMID:19628706; http://dx.doi.org/10.1182/blood-2009-01-200170.
28. Juelich T, Sutcliffe EL, Denton A, He Y, Doherty PC, Parish CR, et al. Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J Immunol 2009; 183:7063-72; PMID:19915065; http://dx.doi. org/10.4049/jimmunol.0901522.
29. Xiao Y, Li B, Zhou Z, Hancock WW, Zhang H, Greene MI. Histone acetyltransferase mediated regulation of FOXP3 acetylation and Treg function. Curr Opin Immunol 2010; 22:583-91; PMID:20869864; http:// dx.doi.org/10.1016/j.coi.2010.08.013.
30. Garcia-Manero G, Fenaux P. Hypomethylating agents and other novel strategies in myelodysplastic syndromes. J Clin Oncol 2011; 29:516-23; PMID:21220589; http://dx.doi.org/10.1200/JCO.2010.31.0854.
31. Kang J, Chen J, Shi Y, Jia J, Zhang Y. Curcumininduced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 2005; 69:1205-13; PMID:15794941; http://dx.doi.org/10.1016/j. bcp.2005.01.014.
32. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727-9; PMID:10426993; http:// dx.doi.org/10.1126/science.285.5428.727.
33. Suárez-Alvarez B, López-Vázquez A, Díaz-Molina B, Bernardo-Rodríguez MJ, Alvarez-López R, Pascual D, et al. The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection. Transplantation 2006; 82:354-61; PMID:16906033; http://dx.doi. org/10.1097/01.tp.0000228911.22944.23.
34. Araki Y, Fann M, Wersto R, Weng NP. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol 2008; 180:8102-8; PMID:18523274.
35. Liu Y, Kuick R, Hanash S, Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009; 130:213-24; PMID:18945643; http://dx.doi.org/10.1016/j. clim.2008.08.009.
36. Liu Y, Chen Y, Richardson B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in "senescent" CD4(+)CD28(-) T cells. Clin Immunol 2009; 132:257-65; PMID:19394279; http:// dx.doi.org/10.1016/j.clim.2009.03.529.
37. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/ nonhistone proteins and histone acetyltransferasedependent chromatin transcription. J Biol Chem 2004; 279:51163-71; PMID:15383533; http://dx.doi. org/10.1074/jbc.M409024200.
38. Gao XN, Lin J, Wang LL, Yu L. Demethylating treatment suppresses natural killer cell cytolytic activity. Mol Immunol 2009; 46:2064-70; PMID:19394699; http://dx.doi.org/10.1016/j.molimm.2009.02.033.
39. Schmiedel BJ, Arélin V, Gruenebach F, Krusch M, Schmidt SM, Salih HR. Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation. Int J Cancer 2011; 128:2911-22; PMID:20960460; http://dx.doi. org/10.1002/ijc.25635.
40. Ogbomo H, Michaelis M, Kreuter J, Doerr HW, Cinatl J Jr. Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett 2007; 581:1317-22; PMID:17349632; http://dx.doi.org/10.1016/j.febslet.2007.02.045.
41. Saikali P, Antel JP, Pittet CL, Newcombe J, Arbour N. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis. J Immunol 2010; 185:5693-703; PMID:20926794; http://dx.doi. org/10.4049/jimmunol.1002188.
42. Tang F, Chen Z, Ciszewski C, Setty M, Solus J, Tretiakova M, et al. Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. J Exp Med 2009; 206:707-19; PMID:19237603; http://dx.doi.org/10.1084/ jem.20071887.
43. Ito A, Shimura H, Nitahara A, Tomiyama K, Ito M, Kanekura T, et al. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Int Immunol 2008; 20:1343-9; PMID:18697765; http://dx.doi. org/10.1093/intimm/dxn092.
44. Feng L, Ke N, Ye Z, Guo Y, Li S, Li Q, et al. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection. Transplant Proc 2009; 41:4332-9; PMID:20005394; http://dx.doi. org/10.1016/j.transproceed.2009.08.060.
45. Joshi M, Dindelegan G, Olausson M, Oltean M. Natural killer group 2 member D cell recruitment driven by major histocompatibility complex class I chain-related antigens A and B: a possible mechanism during acute intestinal allograft rejection in the mouse. Transplant Proc 2010; 42:4467-9; PMID:21168719; http://dx.doi.org/10.1016/j.transproceed.2010.09.115.
46. Gannagé M, Buzyn A, Bogiatzi SI, Lambert M, Soumelis V, Dal Cortivo L, et al. Induction of NKG2D ligands by gamma radiation and tumor necrosis factoralpha may participate in the tissue damage during acute graft-versus-host disease. Transplantation 2008; 85:911-5; PMID:18360276; http://dx.doi. org/10.1097/TP.0b013e31816691ef.
47. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, Bluestone JA, et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 2004; 20:757-67; PMID:15189740; http:// dx.doi.org/10.1016/j.immuni.2004.05.008.
48. Ito Y, Kanai T, Totsuka T, Okamoto R, Tsuchiya K, Nemoto Y, et al. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis. Am J Physiol Gastrointest Liver Physiol 2008; 294:G199-207; PMID:17962357; http://dx.doi. org/10.1152/ajpgi.00286.2007.
49. Andersson AK, Sumariwalla PF, McCann FE, Amjadi P, Chang C, McNamee K, et al. Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis. Arthritis Rheum 2011; 63:2617-29; PMID:21618462; http://dx.doi.org/10.1002/ art.30460.
50. Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier LL. Function of NKG2D in natural killer cellmediated rejection of mouse bone marrow grafts. Nat Immunol 2005; 6:938-45; PMID:16086018; http:// dx.doi.org/10.1038/ni1236.
51. Li J, Zhu H, Wang S, Ye P, Liu C, Wu J, et al. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation. Transplantation 2012; 93:356-63; PMID:22179404; http://dx.doi.org/10.1097/ TP.0b013e31823ffce7.
52. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-86; PMID:10547847.
53. Kottilil S, Shin K, Jackson JO, Reitano KN, O'Shea MA, Yang J, et al. Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions. J Immunol 2006; 176:1107-14; PMID:16393999.
54. Suárez-Alvarez B, Rodriguez RM, Calvanese V, Blanco-Gelaz MA, Suhr ST, Ortega F, et al. Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One 2010; 5:e10192; PMID:20419139; http://dx.doi.org/10.1371/journal.pone.0010192.